Table 2.
Numbers of CRDPs in each category, according to the motoneurone identity and anaesthetic regimen
| Biphasic |
||||||
|---|---|---|---|---|---|---|
| CRDP category | Inspiratory | Expiratory | Type 1 | Type 2 | Biphasic inhibitory | Total |
| External intercostal nerve motoneurones | ||||||
| Ketamine/xylazine | 1 | 1 | — | — | — | 2 |
| Ketamine | — | — | — | — | — | — |
| (Halothane) α-chloralose | — | — | — | — | — | — |
| (Halothane) decerebrate | 1 | — | 1 | 1 | — | 3 |
| Subtotal | 2 | 1 | 1 | 1 | — | 5 |
| Internal intercostal nerve motoneurones | ||||||
| Ketamine/xylazine | 3 | 20 | 3 | 1 | — | 27 |
| Ketamine | 3 | 5 | 1 | — | — | 9 |
| (Halothane) α-chloralose | 1 | 3 | — | — | — | 4 |
| (Halothane) decerebrate | — | 19 | 6 | 14 | 2 | 41 |
| Subtotal | 7 | 47 | 10 | 15 | 2 | 81 |
| Unidentified motoneurones | ||||||
| Ketamine/xylazine | 2 | 2 | 1 | 1 | — | 7* |
| Ketamine | — | — | — | — | — | — |
| (Halothane) α-chloralose | 1 | — | — | — | — | 1 |
| (Halothane) decerebrate | 5 | 4 | — | 1 | 1 | 11 |
| Subtotal | 8 | 6 | 1 | 2 | 1 | 19* |
| Total | 17 | 54 | 12 | 18 | 3 | 105* |
*
Totals include one unidentified motoneurone with ketamine/xylazine in which no CRDP could be detected.